{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:32:10Z","timestamp":1784194330657,"version":"3.55.0"},"reference-count":31,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective.<\/jats:title>\n                  <jats:p>To assess the diagnostic sensitivity and specificity of a Bordetella pertussispolymerase chain reaction (PCR) assay using nasopharyngeal (NP) specimens from subjects with cough illnesses participating in a large pertussis vaccine efficacy trial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design.<\/jats:title>\n                  <jats:p>From 1991 to 1994, we conducted a large pertussis vaccine efficacy trial in Germany to determine the efficacy of the Lederle\/Takeda acellular pertussis component diphtheria-tetanus toxoids in comparison with the Lederle whole-cell component diphtheria-tetanus toxoids vaccine. In the final year of the follow-up period of this trial, a second NP specimen for PCR, in addition to a culture specimen and blood for specific serology (enzyme-linked immunosorbent assay), was collected by use of a Dacron swab in subjects or family members with cough illnesses \u22657 days duration or in subjects with exposure to a cough illness in a household member to establish a diagnosis ofB pertussis infection. Oligonucleotide primers (pTp1 and pTp2) that amplify a 191-bp-sized DNA fragment from the pertussis toxin operon, which is specific for B pertussis, were used. The PCR-amplified products were visualized by dot blot analysis followed by hybridization with a digoxigenin labeled probe and rated as 1+, 2+, or 3+ in comparison with positive controls representing \u223c1 to 10, 11 to 50, and &amp;gt;50 B pertussis organisms, respectively. In the present analysis, we compare PCR findings with those of serology, culture, positive household contact, and clinical characteristics of cough illnesses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Of 392 subjects with NP specimens obtained for PCR, 376 also had NP specimens collected for culture and 282 had serum specimens. PCR and culture were positive in 86 (22%) and 23 (6%) subjects, respectively. Of the positive PCR specimens, 40 were rated 3+, 32 were rated 2+, and 14 were rated 1+; 3+ positive specimens were more prevalent among DT recipients compared with pertussis vaccine recipients. Illnesses in subjects with 3+ positive PCR results were more typical of pertussis than were those in subjects with 2+ and 1+ positive results with a mean duration of cough of 48 days versus 43 and 42 days, respectively; presence of paroxysms, whoop or vomiting in 38% versus 17% and 10%, respectively; and a clinical diagnosis of definite or probable pertussis by the investigators of 26% versus 7% and 4%, respectively. Using serologic evidence of infection as the standard, sensitivity of PCR was 61%, and specificity was 88%. For 3+ positive PCR results, the respective values were 42% and 97%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion.<\/jats:title>\n                  <jats:p>Our findings demonstrate that PCR is more sensitive than conventional culture for the diagnosis of pertussis. They also demonstrate a high specificity of PCR when serology with or without other confirmative criteria (culture and household contact) is used as the reference. Analysis of semiquantitative PCR results revealed that subjects with a 3+ PCR more frequently experienced typical illness compared with patients with 1+ or 2+ PCR. Although specific serologic study remains a necessity in pertussis research its modification for diagnosis in the clinical setting results in low sensitivity and specificity. Therefore, because PCR is more sensitive than culture and is easy to perform, it is a useful addition in the clinical setting.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.105.3.e31","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:50:41Z","timestamp":1092441041000},"page":"e31-e31","source":"Crossref","is-referenced-by-count":65,"title":["Clinical Validation of a Polymerase Chain Reaction Assay for the Diagnosis of Pertussis by Comparison With Serology, Culture, and Symptoms During a Large Pertussis Vaccine Efficacy Trial"],"prefix":"10.1542","volume":"105","author":[{"given":"Ulrich","family":"Heininger","sequence":"first","affiliation":[{"name":"From Hospital for Children and Adolescents of the Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Schmidt-Schla\u0308pfer","sequence":"additional","affiliation":[{"name":"University Children's Hospital, Basel, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Cherry","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and the UCLA Center for Vaccine Research, University of California Los Angeles School of Medicine, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Stehr","sequence":"additional","affiliation":[{"name":"From Hospital for Children and Adolescents of the Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2000,3,1]]},"reference":[{"key":"2021121003084986900_B1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis-toxoid vaccine.","volume":"333","author":"Trollfors","year":"1995","journal-title":"N Engl J Med"},{"key":"2021121003084986900_B2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis.","volume":"334","author":"Greco","year":"1996","journal-title":"N Engl J Med"},{"key":"2021121003084986900_B3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"2021121003084986900_B4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0022-3476(97)70234-8","article-title":"Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis.","volume":"130","author":"Trollfors","year":"1997","journal-title":"J Pediatr"},{"key":"2021121003084986900_B5","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.","volume":"15","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"2021121003084986900_B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.101.1.1","article-title":"A comparative efficacy trial in Germany in infants who received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine.","volume":"101","author":"Stehr","year":"1998","journal-title":"Pediatrics"},{"key":"2021121003084986900_B7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/peds.102.4.909","article-title":"The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial.","volume":"102","author":"Cherry","year":"1998","journal-title":"Pediatrics"},{"key":"2021121003084986900_B8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1542\/peds.102.3.546","article-title":"Comparative efficacy of the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German infants following household exposure.","volume":"102","author":"Heininger","year":"1998","journal-title":"Pediatrics"},{"key":"2021121003084986900_B9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/515154","article-title":"Evidence of efficacy of the Lederle\/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.","volume":"28","author":"Heininger","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2021121003084986900_B10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00006454-199306000-00009","article-title":"Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany.","volume":"12","author":"Heininger","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"2021121003084986900_B11"},{"key":"2021121003084986900_B12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0923-2508(89)90069-7","article-title":"Specific identification of Bordetella pertussis by the polymerase chain reaction.","volume":"140","author":"Houard","year":"1989","journal-title":"Res Microbiol"},{"key":"2021121003084986900_B13","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1128\/jcm.28.9.1982-1987.1990","article-title":"Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction.","volume":"28","author":"Glare","year":"1990","journal-title":"J Clin Microbiol"},{"key":"2021121003084986900_B14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00365549209061340","article-title":"Amplification of DNA by the polymerase chain reaction for the efficient diagnosis of pertussis.","volume":"24","author":"Olcen","year":"1992","journal-title":"Scand J Infect Dis"},{"key":"2021121003084986900_B15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1099\/00222615-38-2-140","article-title":"Identification of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cyclase gene.","volume":"38","author":"Douglas","year":"1993","journal-title":"J Med Microbiol"},{"key":"2021121003084986900_B16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0732-8893(93)90094-N","article-title":"Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchiseptica.","volume":"17","author":"Reizenstein","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021121003084986900_B17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF01967443","article-title":"Use of the polymerase chain reaction to detect Bordetella pertussis in patients with mild or atypical symptoms of infection.","volume":"12","author":"Schla\u0308pfer","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021121003084986900_B18","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/jcm.31.8.2134-2140.1993","article-title":"Polymerase chain reaction assay for pertussis: simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis.","volume":"31","author":"van der Zee","year":"1993","journal-title":"J Clin Microbiol"},{"key":"2021121003084986900_B19","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/jcm.31.10.2745-2750.1993","article-title":"Comparison of polymerase chain reaction, culture and western immunoblot serology for diagnosis of Bordetella pertussis infection.","volume":"31","author":"Grimprel","year":"1993","journal-title":"J Clin Microbiol"},{"key":"2021121003084986900_B20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3476(94)70365-5","article-title":"Sensitive and specific polymerase chain reaction assays for detection of Bordetella pertussis in nasopharyngeal specimens.","volume":"124","author":"He","year":"1994","journal-title":"J Pediatr"},{"key":"2021121003084986900_B21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/jcm.32.3.783-789.1994","article-title":"Identification of Bordetella pertussis infection by shared-primer PCR.","volume":"32","author":"Li","year":"1994","journal-title":"J Clin Microbiol"},{"key":"2021121003084986900_B22","first-page":"161","article-title":"Identification of B. pertussis in nasopharyngeal swabs using the polymerase chain reaction: evaluation of detection methods.","volume":"32","author":"Lichtinghagen","year":"1994","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"2021121003084986900_B23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-199503000-00008","article-title":"Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany.","volume":"14","author":"Schla\u0308pfer","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"2021121003084986900_B24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1099\/00222615-44-4-261","article-title":"Polymerase chain reaction for the detection of Bordetella pertussis in clinical nasopharyngeal aspirates.","volume":"44","author":"Mastrantonio","year":"1996","journal-title":"J Med Microbiol"},{"key":"2021121003084986900_B25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/jcm.34.4.810-815.1996","article-title":"Validation of nested Bordetella PCR in a pertussis vaccine trial.","volume":"34","author":"Reizenstein","year":"1996","journal-title":"J Clin Microbiol"},{"key":"2021121003084986900_B26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/infdis\/174.1.89","article-title":"A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population.","volume":"174","author":"van der Zee","year":"1996","journal-title":"J Infect Dis"},{"key":"2021121003084986900_B27","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1699-0463.1998.tb00256.x","article-title":"Quantification of Bordetella pertussis in clinical samples by colorimetric detection of competitive PCR products.","volume":"106","author":"Erlandsson","year":"1998","journal-title":"APMIS"},{"key":"2021121003084986900_B28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/JCM.36.3.679-683.1998","article-title":"Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections.","volume":"36","author":"Lind-Brandberg","year":"1998","journal-title":"J Clin Microbiol"},{"key":"2021121003084986900_B29","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/jcm.35.10.2435-2443.1997","article-title":"Laboratory diagnosis of pertussis: state of the art in 1997.","volume":"35","author":"Mu\u0308ller","year":"1997","journal-title":"J Clin Microbiol"},{"key":"2021121003084986900_B30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1099\/00222615-41-1-51","article-title":"Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections.","volume":"41","author":"Meade","year":"1994","journal-title":"J Med Microbiol"},{"key":"2021121003084986900_B31","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00006454-199410000-00020","article-title":"Environmental contamination leading to false-positive polymerase chain reaction for pertussis.","volume":"13","author":"Taranger","year":"1994","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/105\/3\/e31\/840960\/e31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/105\/3\/e31\/840960\/e31.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T09:39:23Z","timestamp":1639129163000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/105\/3\/e31\/62683\/Clinical-Validation-of-a-Polymerase-Chain-Reaction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,1]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2000,3,1]]},"published-print":{"date-parts":[[2000,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.105.3.e31","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3,1]]}}}